Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Merlini

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|September 28, 2022
Being the ultimate travel companion of a patient with uterine leiomyosarcomaGiovanni Grignani, Alessandra Merlini, Sandra Aliberti
Expert Review of Anticancer Therapy|August 5, 2024
Progress in histology specific treatments in soft tissue sarcomaStefano Radaelli, Alessandra Merlini, Misbah Khan, et al.
Biomedicines|October 27, 2022
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19Letizia Vitali, Alessandra Merlini, Federica Galvagno, et al.
Cell Communication and Signaling : CCS|September 9, 2024
Targeting the EphA2 pathway: could it be the way for bone sarcomas?Giorgia Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Pharmacology & Therapeutics|November 23, 2019
Delving into PARP inhibition from bench to bedside and backGiovanni Grignani, Alessandra Merlini, Dario Sangiolo, et al.
Hematology/Oncology Clinics of North America|May 14, 2025
Approaches to Ultra-Rare Sarcomas: Definitions, Diagnostics, and TherapiesAlessandra Merlini, Angelo Paolo Dei Tos, Pan Pantziarka, et al.
Future Oncology (London, England)|January 10, 2020
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case reportSandra Aliberti, Sara Miano, Francesco Tolomeo, et al.
Future Oncology (London, England)|October 6, 2022
Experience with second-line trabectedin in daily clinical practice: case studiesJavier Martín-Broto, Nadia Hindi, Giovanni Grignani, et al.
Life (Basel, Switzerland)|June 28, 2023
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare SubtypesAndrea Mogavero, Paolo Bironzo, Luisella Righi, et al.
Frontiers in Oncology|February 6, 2023
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directionsAlessandra Merlini, Valeria Pavese, Giulia Manessi, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|September 28, 2022
Being the ultimate travel companion of a patient with uterine leiomyosarcomaGiovanni Grignani, Alessandra Merlini, Sandra Aliberti
Expert Review of Anticancer Therapy|August 5, 2024
Progress in histology specific treatments in soft tissue sarcomaStefano Radaelli, Alessandra Merlini, Misbah Khan, et al.
Biomedicines|October 27, 2022
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19Letizia Vitali, Alessandra Merlini, Federica Galvagno, et al.
Cell Communication and Signaling : CCS|September 9, 2024
Targeting the EphA2 pathway: could it be the way for bone sarcomas?Giorgia Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Pharmacology & Therapeutics|November 23, 2019
Delving into PARP inhibition from bench to bedside and backGiovanni Grignani, Alessandra Merlini, Dario Sangiolo, et al.
Hematology/Oncology Clinics of North America|May 14, 2025
Approaches to Ultra-Rare Sarcomas: Definitions, Diagnostics, and TherapiesAlessandra Merlini, Angelo Paolo Dei Tos, Pan Pantziarka, et al.
Future Oncology (London, England)|January 10, 2020
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case reportSandra Aliberti, Sara Miano, Francesco Tolomeo, et al.
Future Oncology (London, England)|October 6, 2022
Experience with second-line trabectedin in daily clinical practice: case studiesJavier Martín-Broto, Nadia Hindi, Giovanni Grignani, et al.
Life (Basel, Switzerland)|June 28, 2023
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare SubtypesAndrea Mogavero, Paolo Bironzo, Luisella Righi, et al.
Frontiers in Oncology|February 6, 2023
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directionsAlessandra Merlini, Valeria Pavese, Giulia Manessi, et al.
Pageof 5